Latest Industry Insights

Technology Networks spoke with Dr. Richard Cuthbert, cell biology product manager at Bio-Rad, to learn more about Bio-Rad's new ZE5 Cell Analyzer, the challenges within the field and recent technological advancements in flow cytometry.

To learn about the progress being made in the RNA therapeutics space, we spoke to CTO and Co-Founder of La Jolla Labs, Jeff Milton, at the 2025 SLAS international meeting in San Diego.

Labs have been using "mobile devices" – paper and pencil – for centuries. Now it's time to embrace "modern" mobile devices.

Gilberto Barcellos and Dr. Melanie Bailey discuss the growing interest in single-cell lipidomics, the key challenges researchers face and how the SS2000 is helping to overcome these hurdles.

UK Biocentre is adopting Azenta’s BioArc™ Ultra™, an automated -80°C storage system, to enhance biobanking efficiency and sustainability. With high-density storage and precise temperature control, it safeguards valuable samples.

Dr. John Lee, global head of cell and gene therapy at SK pharmteco discusses the current challenges in plasmid manufacturing and how SK pharmteco’s Precision Plasmids™ technology can help overcome plasmid production bottlenecks.

Traditional chromatographic techniques raise significant environmental concerns. Addressing these issues is critical to making chromatography not only a powerful analytical tool but a more eco-friendly and responsible choice for future applications.

Mary Kay Bates, senior global cell culture scientist at Thermo Fisher Scientific, explores best practices for implementing GMP regulations in the lab.

Louise Digby, vice president of enzymes and bioproduction at BioProduction by SEKISUI, discusses some of the current challenges in scaling microbial fermentation for biopharmaceutical production and how a CDMO can help overcome these challenges.

A new collaborative trial is exploring how music and VR could provide a personalized anxiety treatment. Technology Networks spoke with the team behind the trial to learn more.